NasdaqGS - Delayed Quote USD

Apyx Medical Corporation (APYX)

1.4100 0.0000 (0.00%)
At close: May 15 at 4:00 PM EDT
1.3918 -0.02 (-1.29%)
After hours: May 15 at 4:18 PM EDT
Loading Chart for APYX
DELL
  • Previous Close 1.4100
  • Open 1.4000
  • Bid 1.4000 x 200
  • Ask 1.8000 x 200
  • Day's Range 1.4000 - 1.4300
  • 52 Week Range 1.2100 - 7.9700
  • Volume 25,966
  • Avg. Volume 156,845
  • Market Cap (intraday) 49.541M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.6600
  • Earnings Date Aug 8, 2024 - Aug 12, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.63

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

apyxmedical.com

252

Full Time Employees

December 31

Fiscal Year Ends

Recent News: APYX

Performance Overview: APYX

Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

APYX
46.18%
S&P 500
11.29%

1-Year Return

APYX
73.69%
S&P 500
28.71%

3-Year Return

APYX
85.55%
S&P 500
27.18%

5-Year Return

APYX
75.48%
S&P 500
87.28%

Compare To: APYX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: APYX

Valuation Measures

Annual
As of 5/14/2024
  • Market Cap

    48.85M

  • Enterprise Value

    50.19M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.97

  • Price/Book (mrq)

    2.41

  • Enterprise Value/Revenue

    0.99

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -45.20%

  • Return on Assets (ttm)

    -20.30%

  • Return on Equity (ttm)

    -80.84%

  • Revenue (ttm)

    50.45M

  • Net Income Avi to Common (ttm)

    -22.81M

  • Diluted EPS (ttm)

    -0.6600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    37.28M

  • Total Debt/Equity (mrq)

    188.78%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: APYX

Company Insights: APYX

Research Reports: APYX

People Also Watch